About us
In brief
The Board of Directors
Management Team
Corporate Governance
Intellectual Properties
Partnerships
Environment & quality
Human Resources
Career
Project portfolio
Project overview
Research areas
Development phases
Publications
Contract Research
Autoradiography
Pharmacokinetics & Metabolism
Analytical chemistry
Disease models
Investor info
Contacts
Press releases
Stock
Interim reports
Annual reports
Presentations
Ownership
Official documents
Calender
Press & news
Press releases
Interim reports
Annual reports
Features
Image bank
Calender
Contacts
Reports
Contact
Contacts
Visit us
FAQ
Press & news
Press releases
Interim reports
Annual reports
Features
Image bank
Calender
Contacts
Reports
Features
ANYARA – the targeted cancer therapy
In the ANYARA project, Active Biotech is developing a method for combating cancer. The body´s own immune defense is stimulated with a targeted immune activator that helps T cells track and kill cancer cells. »»
Development in harmony with official requirements
The pharmaceutical industry is the most regulated industry there is. Authorities in various countries oversee pharmaceutical companies in the development, testing, production and marketing/selling of their products. »»
Microscopic dose means microscopic risk
New technology makes it possible to conduct initial clinical trials with microscopically small doses of new pharmaceutical substances. The method is called microdosing. »»
Advanced search
Active Biotech AB, Scheelevägen 22, P.O. Box 724, SE-220 07 Lund, Sweden, Telephone +46 46 19 20 00